Iovance updates corporate presentation
- Filed Form 8-K on October 5, 2026.
- Updated corporate presentation for conferences and analysts.
- Presentation includes financial guidance and pipeline updates.
Every EDGAR filing for IOVANCE BIOTHERAPEUTICS, INC. (IOVA), newest first, with AI summaries and stories.
Next: earnings expected ~Nov 9 · 10-Q expected ~Nov 9 (deadline Nov 9)
No open-market insider buys in the last 30 days.
Every filing, newest first. MAJOR and NOTABLE filings lead the app's feed; ROUTINE ones are kept here.
Noah Berkowitz, new insider at IOVA
Noah Berkowitz
Igor Bilinsky, insider filing for IOVA
Igor Bilinsky, reporting
Frederick G Vogt, insider filing for IOVA
Frederick G Vogt, reporting
Daniel Gordon Kirby, insider filing for IOVA
Daniel Gordon Kirby, reporting
Corleen M. Roche, insider filing for IOVA
Corleen M. Roche, reporting
Ownership stake disclosure by STATE STREET CORP
STATE STREET CORP, filed by
Ownership stake disclosure by BlackRock, Inc. (amended)
BlackRock, Inc., filed by
Michael Weiser, insider filing for IOVA
Michael Weiser, reporting
Frederick G Vogt, insider filing for IOVA
Frederick G Vogt, reporting
Frederick G Vogt, insider filing for IOVA
Frederick G Vogt, reporting
Daniel Gordon Kirby, insider filing for IOVA
Daniel Gordon Kirby, reporting
Ownership stake disclosure by STATE STREET CORP
STATE STREET CORP, filed by
Ownership stake disclosure by VANGUARD GROUP INC (amended)
VANGUARD GROUP INC, filed by
Corleen M. Roche, insider filing for IOVA
Corleen M. Roche, reporting